EP1487783A4 - Irreversible selective androgen receptor modulators and methods of use thereof - Google Patents
Irreversible selective androgen receptor modulators and methods of use thereofInfo
- Publication number
- EP1487783A4 EP1487783A4 EP03710820A EP03710820A EP1487783A4 EP 1487783 A4 EP1487783 A4 EP 1487783A4 EP 03710820 A EP03710820 A EP 03710820A EP 03710820 A EP03710820 A EP 03710820A EP 1487783 A4 EP1487783 A4 EP 1487783A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- methods
- androgen receptor
- receptor modulators
- selective androgen
- irreversible selective
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/02—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
- C07C233/04—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C233/05—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/26—Cyanate or isocyanate esters; Thiocyanate or isothiocyanate esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/16—Masculine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/28—Antiandrogens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C255/50—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton to carbon atoms of non-condensed six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C261/00—Derivatives of cyanic acid
- C07C261/02—Cyanates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C265/00—Derivatives of isocyanic acid
- C07C265/12—Derivatives of isocyanic acid having isocyanate groups bound to carbon atoms of six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C331/00—Derivatives of thiocyanic acid or of isothiocyanic acid
- C07C331/02—Thiocyanates
- C07C331/10—Thiocyanates having sulfur atoms of thiocyanate groups bound to carbon atoms of hydrocarbon radicals substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C331/00—Derivatives of thiocyanic acid or of isothiocyanic acid
- C07C331/16—Isothiocyanates
- C07C331/28—Isothiocyanates having isothiocyanate groups bound to carbon atoms of six-membered aromatic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Reproductive Health (AREA)
- Emergency Medicine (AREA)
- Ophthalmology & Optometry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US8467902A | 2002-02-28 | 2002-02-28 | |
US453704P | 2002-02-28 | ||
US42024802P | 2002-10-23 | 2002-10-23 | |
US420248P | 2002-10-23 | ||
PCT/US2003/003121 WO2003074473A2 (en) | 2002-02-28 | 2003-02-24 | Irreversible selective androgen receptor modulators and methods of use thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1487783A2 EP1487783A2 (en) | 2004-12-22 |
EP1487783A4 true EP1487783A4 (en) | 2006-09-27 |
Family
ID=27791168
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP03710820A Withdrawn EP1487783A4 (en) | 2002-02-28 | 2003-02-24 | Irreversible selective androgen receptor modulators and methods of use thereof |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP1487783A4 (en) |
JP (1) | JP2005519111A (en) |
KR (1) | KR20040104463A (en) |
CN (1) | CN1646479A (en) |
AU (1) | AU2003214971A1 (en) |
CA (1) | CA2476651A1 (en) |
EA (1) | EA200401121A1 (en) |
HR (1) | HRP20040851A2 (en) |
IL (1) | IL163742A0 (en) |
MX (1) | MXPA04008412A (en) |
TW (1) | TW200304806A (en) |
WO (1) | WO2003074473A2 (en) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040260108A1 (en) * | 2001-06-25 | 2004-12-23 | Dalton James T. | Metabolites of selective androgen receptor modulators and methods of use thereof |
US7214693B2 (en) * | 2002-10-15 | 2007-05-08 | University Of Tennessee Research Foundation | Heterocyclic selective androgen receptor modulators and methods of use thereof |
EP1562594A4 (en) * | 2002-10-15 | 2008-12-17 | Univ Tennessee Res Foundation | Methylene-bridged selective androgen receptor modulators and methods of use thereof |
US7968721B2 (en) * | 2003-01-13 | 2011-06-28 | University Of Tennessee Research Foundation | Large-scale synthesis of selective androgen receptor modulators |
US20050032750A1 (en) * | 2003-01-22 | 2005-02-10 | Steiner Mitchell S. | Treating androgen deficiency in female (ADIF)-associated conditions with SARMS |
MXPA06000119A (en) * | 2003-12-16 | 2006-03-21 | Gtx Inc | Prodrugs of selective androgen receptor modulators and methods of use thereof. |
WO2005080320A1 (en) | 2004-02-13 | 2005-09-01 | Warner-Lambert Company Llc | Androgen receptor modulators |
EP1737813A1 (en) | 2004-04-13 | 2007-01-03 | Warner-Lambert Company LLC | Androgen modulators |
CA2562672C (en) | 2004-04-22 | 2009-09-29 | Warner-Lambert Company Llc | 4-cyano-phenoxy derivatives as androgen modulators |
UA87854C2 (en) | 2004-06-07 | 2009-08-25 | Мерк Энд Ко., Инк. | N-(2-benzyl)-2-phenylbutanamides as androgen receptor modulators |
BRPI0513020A (en) | 2004-07-08 | 2008-04-22 | Warner Lambert Co | androgen modulators, their uses, pharmaceutical composition, topical pharmaceutical formulation and article of manufacture |
BRPI0514469A (en) * | 2004-08-18 | 2008-06-10 | Warner Lambert Co | androgen modulators |
TW200724139A (en) | 2005-05-05 | 2007-07-01 | Warner Lambert Co | Androgen modulators |
PL3086784T3 (en) * | 2013-12-23 | 2019-09-30 | Bcn Peptides, S.A. | Bicalutamide analogs or (s)-bicalutamide as exocytosis activating compounds for use in the treatment of a lysosomal storage disorder or glycogenosis |
US10865184B2 (en) | 2015-04-21 | 2020-12-15 | University Of Tennessee Research Foundation | Selective androgen receptor degrader (SARD) ligands and methods of use thereof |
US10654809B2 (en) | 2016-06-10 | 2020-05-19 | University Of Tennessee Research Foundation | Selective androgen receptor degrader (SARD) ligands and methods of use thereof |
US10093613B2 (en) | 2015-04-21 | 2018-10-09 | Gtx, Inc. | Selective androgen receptor degrader (SARD) ligands and methods of use thereof |
US10806720B2 (en) | 2015-04-21 | 2020-10-20 | University Of Tennessee Research Foundation | Selective androgen receptor degrader (SARD) ligands and methods of use thereof |
US11230523B2 (en) | 2016-06-10 | 2022-01-25 | University Of Tennessee Research Foundation | Selective androgen receptor degrader (SARD) ligands and methods of use thereof |
KR102481319B1 (en) * | 2016-06-10 | 2022-12-26 | 유니버시티 오브 테네시 리서치 파운데이션 | Selective Androgen Receptor Degrader (SARD) Ligands and Methods of Use Thereof |
CN113137836B (en) * | 2021-04-23 | 2023-04-07 | 柳州东风容泰化工股份有限公司 | Drying method and system for preparing o-chlorobenzonitrile |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998053826A1 (en) * | 1997-05-30 | 1998-12-03 | The University Of Tennessee Research Corporation | Non-steroidal agonist compounds and their use in male hormone therapy |
WO2002016310A1 (en) * | 2000-08-24 | 2002-02-28 | The University Of Tennessee Research Corporation | Selective androgen receptor modulators and methods of use thereof |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6071957A (en) * | 1996-11-27 | 2000-06-06 | The University Of Tennessee Research Corporation | Irreversible non-steroidal antagonist compound and its use in the treatment of prostate cancer |
-
2003
- 2003-02-24 CA CA002476651A patent/CA2476651A1/en not_active Abandoned
- 2003-02-24 MX MXPA04008412A patent/MXPA04008412A/en unknown
- 2003-02-24 KR KR10-2004-7013473A patent/KR20040104463A/en not_active Application Discontinuation
- 2003-02-24 WO PCT/US2003/003121 patent/WO2003074473A2/en not_active Application Discontinuation
- 2003-02-24 AU AU2003214971A patent/AU2003214971A1/en not_active Abandoned
- 2003-02-24 CN CNA038047187A patent/CN1646479A/en active Pending
- 2003-02-24 EP EP03710820A patent/EP1487783A4/en not_active Withdrawn
- 2003-02-24 IL IL16374203A patent/IL163742A0/en unknown
- 2003-02-24 JP JP2003572945A patent/JP2005519111A/en active Pending
- 2003-02-24 EA EA200401121A patent/EA200401121A1/en unknown
- 2003-02-27 TW TW092104206A patent/TW200304806A/en unknown
-
2004
- 2004-09-16 HR HR20040851A patent/HRP20040851A2/en not_active Application Discontinuation
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998053826A1 (en) * | 1997-05-30 | 1998-12-03 | The University Of Tennessee Research Corporation | Non-steroidal agonist compounds and their use in male hormone therapy |
WO2002016310A1 (en) * | 2000-08-24 | 2002-02-28 | The University Of Tennessee Research Corporation | Selective androgen receptor modulators and methods of use thereof |
Non-Patent Citations (2)
Title |
---|
DALTON J T ET AL: "Discovery of nonsteroidal androgens", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, ACADEMIC PRESS INC. ORLANDO, FL, US, vol. 244, no. 1, 1998, pages 1 - 4, XP002385138, ISSN: 0006-291X * |
KIRKOVSKY L. ET AL: "Chiral nonsteroidal affinity ligands for the androgen receptor. 1. Bicalutamide analogues bearing electrophilic groups in the B aromatic ring", JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY. WASHINGTON, US, vol. 43, no. 4, 24 February 2000 (2000-02-24), pages 581 - 590, XP002207426, ISSN: 0022-2623 * |
Also Published As
Publication number | Publication date |
---|---|
EA200401121A1 (en) | 2005-10-27 |
JP2005519111A (en) | 2005-06-30 |
CA2476651A1 (en) | 2003-09-12 |
MXPA04008412A (en) | 2005-05-17 |
EP1487783A2 (en) | 2004-12-22 |
HRP20040851A2 (en) | 2005-02-28 |
TW200304806A (en) | 2003-10-16 |
CN1646479A (en) | 2005-07-27 |
WO2003074473A3 (en) | 2003-12-18 |
KR20040104463A (en) | 2004-12-10 |
IL163742A0 (en) | 2005-12-18 |
AU2003214971A1 (en) | 2003-09-16 |
WO2003074473A2 (en) | 2003-09-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL165792A0 (en) | N-bridged selective androgen receptor modulators and methods of use thereof | |
EP1562906A4 (en) | Heterocyclic selective androgen receptor modulators and methods of use thereof | |
EP1562594A4 (en) | Methylene-bridged selective androgen receptor modulators and methods of use thereof | |
IL163742A0 (en) | Irreversible selective androgen receptor modulators and methods of use thereof | |
EP1420796A4 (en) | Androgen receptor modulators and methods of use thereof | |
IL154425A0 (en) | Selective androgen receptor modulators and methods of use thereof | |
IL178717A0 (en) | Metabolites of selective androgen receptor modulators and methods of use thereof | |
AU2003251970A8 (en) | Modulators of the glucocorticoid receptor and method | |
IL163744A (en) | Multi-substituted selective androgen receptor modulators and uses thereof | |
IL172042A0 (en) | Prodrugs of selective androgen receptor and methods of use thereof | |
AU2003259717A8 (en) | Modulators of rabggt and methods of use thereof | |
EP1718626A4 (en) | Sulfonylpyrrolodine modulators of androgen receptor fuction and method | |
AU2003288902A8 (en) | Microcapsules and methods of use | |
EP1691729A4 (en) | Encapsulation device and methods of use | |
EP1521747A4 (en) | Receptor-type kinase modulators and methods of use | |
AU2003294264A8 (en) | Non-steroidal farnesoid x receptor modulators and methods for the use thereof | |
EP1663204A4 (en) | C-kit modulators and methods of use | |
SI1521733T1 (en) | Modulators of the glucocorticoid receptor | |
AU2003290869A8 (en) | Embolization device and a method of using the same | |
HK1079789A1 (en) | Vasculostatic agents and methods of use thereof | |
EP1474445A4 (en) | Glycoisoforms of adiponectin and uses thereof | |
EP1610774A4 (en) | Tie-2 modulators and methods of use | |
EP1611123A4 (en) | Tie-2 modulators and methods of use | |
EP1622567A4 (en) | Androgen receptor modulators and methods of use thereof | |
EP1591062A4 (en) | Magnetoencephalography device and method of using the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20040928 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT SE SI SK TR |
|
AX | Request for extension of the european patent |
Extension state: AL LT LV MK RO |
|
RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: MUKHERJEE, ARNAB Inventor name: VEVERKA, KAREN, A. Inventor name: STEINER, MITCHELL, S. Inventor name: HWANG, DONG JIN Inventor name: KIRKOVSKY, LEONID, I. Inventor name: MILLER, DUANE, D. Inventor name: DALTON, JAMES |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1068130 Country of ref document: HK |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20060824 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20060901 |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: WD Ref document number: 1068130 Country of ref document: HK |